QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nanovibronix-q2-eps-025-up-from-065-yoy-sales-81700m-up-from-39400k-yoy

NanoVibronix (NASDAQ:NAOV) reported quarterly losses of $(0.25) per share. This is a 61.54 percent increase over losses of $(0....

 nanovibronix-presents-uroshield-clinical-study-at-the-university-of-michigan

NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface A...

 nanovibronix-q1-eps-023-up-from-067-yoy-sales-92100k-up-from-35400k-yoy

NanoVibronix (NASDAQ:NAOV) reported quarterly losses of $(0.23) per share. This is a 65.67 percent increase over losses of $(0....

 nanovibronix-and-va-supplier-cb-medical-announce-distribution-agreement-for-theuroshield

NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the...

 nanovibronix-announces-painshield-to-be-included-in-department-of-veteran-affairs-fss-contract-award-effective-may-1-2024

Distribution Partner, Delta Medical, Awarded a Five-Year Federal Supply Schedule Contract for PainShield by Department of Veter...

 nanovibronix-issues-letter-to-stockholders

We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, whi...

 nanovibronix-signs-agreement-for-research-and-development-of-next-generation-painshield-and-uroshield

Efforts Focused on Adding Therapeutic Functionality and Reducing CostsNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" ...

 nanovibronix-shares-resume-trade
NanoVibronix Shares Resume Trade
01/25/2024 16:14:12

 nanovibronix-announces-agreement-for-clinical-study-of-uroshield-at-the-university-of-michigan

Gathering Additional Clinical Evidence to Support Application to FDA for Permanent ClearanceNanoVibronix, Inc. (NASDAQ:NAOV), a...

 nanovibronix-regains-nasdaq-compliance

NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield® and PainShield...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION